Janusz Puc
56 works · 7,275 citations · h-index 13
Top works
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
- An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten +/− mice
- Somatic mutations of PTEN in glioblastoma multiforme.
- Lack of PTEN sequesters CHK1 and initiates genetic instability
- A Histone H2A Deubiquitinase Complex Coordinating Histone Acetylation and H1 Dissociation in Transcriptional Regulation
- Cell cycle checkpoint defects contribute to genomic instability in PTEN deficient cells independent of DNA DSB repair
- PTEN Loss Inhibits CHK1 to Cause Double Stranded-DNA Breaks in Cells
- Ligand-Dependent Enhancer Activation Regulated by Topoisomerase-I Activity
- Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress
- Physiological functions of programmed DNA breaks in signal-induced transcription
- Bispecific CAR T Cells against EpCAM and Inducible ICAM-1 Overcome Antigen Heterogeneity and Generate Superior Antitumor Responses
- Inducible expression of interleukin-12 augments the efficacy of affinity-tuned chimeric antigen receptors in murine solid tumor models
- SOX2 and CHD7 cooperatively regulate human disease genes
- Analysis of PTEN Mutation in Non‐familial Pheochromocytoma
- Safety and efficacy of AIC100 chimeric antigen receptor (CAR) T-cell therapy in patients with advanced thyroid cancers: Results from the phase 1 study.
- Mitochondrial activity after cold preservation of pancreatic islet cells treated with pefloxacin (PFX).
- Safety and early efficacy results of phase 1 study of affinity tuned and trackable AIC100 CAR T cells in ICAM-1 positive relapsed and/or refractory advanced poorly differentiated and anaplastic thyroid cancers.
- Phase I study of AIC100 in relapsed and/or refractory advanced thyroid cancer and anaplastic thyroid cancer.
- Chimeric Antigen Receptor T Cell Therapy Targeting Epithelial Cell Adhesion Molecule in Gastric Cancer: Mechanisms of Tumor Resistance
- Abstract 6598: Eradication of EpCAM expressing solid tumors by low-affinity CAR T cells